We went on to determine the cellular mechanism of miR-509-mediated B-ALL growth inhibition and identify RAB5C as a key B-ALL growth-promoting factor targeted by miR-509. This evidence concerns the gene RAB5C and precursor B-cell acute lymphoblastic leukemia.